Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In HungaryA 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients with Bipolar I Disorder
Original registry wording; source language not specified.
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In HungaryThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BulgariaA Randomized, DB, PC and AC, Parallel Group, Dose-Response Study to Evaluate the Efficacy and Safety of 3 Fixed Dosages of Extended Release OROS� Paliperidone (6, 9, 12 mg/Day) and Olanzapine (10 mg/Day), With Open-Label Extension, in the Treatment of Subjects With Schizophrenia - Open Label Phase
This study has finished and is no longer accepting participants.
Location not clearly listedThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In CroatiaA Prospective Randomized Open-label 6-Month Head-To-Head Trial to Compare Metabolic Effects of Paliperidone ER and Olanzapine in Subjects With Schizophrenia
This study has finished and is no longer accepting participants.
Multiple locations, including Buenos AiresThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In SpainResearchers compared MG01CI (1400 mg) and placebo to find out how the approaches affected ADHD symptoms in adults with ADHD.
This study has finished and is no longer accepting participants.
Multiple locations, including Gainesville
Phase 2 Study of the Effect of add-on Sulforaphane in Treatment of Schizophrenia
This study has finished and is no longer accepting participants.
Location not clearly listedA 6-month Study to Evaluate Sulforaphane add-on Effects in Treatment of Negative Symptoms and Cognition Impairment of Schizophrenia Patients
This study has finished and is no longer accepting participants.
In ChangshaThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BelgiumThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In Czech RepublicWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.